216 related articles for article (PubMed ID: 29303101)
1. [Testosterone therapy: indications and risks].
Maatje MGF; Dinkelman-Smit M; Boellaard WPA; Dohle GR
Ned Tijdschr Geneeskd; 2018; 162():D1947. PubMed ID: 29303101
[TBL] [Abstract][Full Text] [Related]
2. Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
Permpongkosol S; Khupulsup K; Leelaphiwat S; Pavavattananusorn S; Thongpradit S; Petchthong T
J Sex Med; 2016 Aug; 13(8):1199-211. PubMed ID: 27436076
[TBL] [Abstract][Full Text] [Related]
3. Current topics in testosterone replacement of hypogonadal men.
Nieschlag E
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
[TBL] [Abstract][Full Text] [Related]
4. Testosterone therapy in older men with late-onset hypogonadism: a counter-rationale.
Basaria S
Endocr Pract; 2013; 19(5):853-63. PubMed ID: 24014017
[TBL] [Abstract][Full Text] [Related]
5. Testosterone for 'late-onset hypogonadism' in men?
Drug Ther Bull; 2010 Jun; 48(6):69-72. PubMed ID: 20530029
[TBL] [Abstract][Full Text] [Related]
6. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints.
Permpongkosol S; Tantirangsee N; Ratana-olarn K
J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330
[TBL] [Abstract][Full Text] [Related]
7. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
Morales A; Black AM; Emerson LE
BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790
[TBL] [Abstract][Full Text] [Related]
8. IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.
Zitzmann M; Mattern A; Hanisch J; Gooren L; Jones H; Maggi M
J Sex Med; 2013 Feb; 10(2):579-88. PubMed ID: 22812645
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratoristic strategy in late onset hypogonadism.
Lombardo F; Lupini C; Meola A; Pallotti F; Gandini L; Lenzi A
Acta Biomed; 2010; 81 Suppl 1():85-8. PubMed ID: 20518196
[TBL] [Abstract][Full Text] [Related]
10. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
Amano T
Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
12. Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2.
Wu F; Zitzmann M; Heiselman D; Donatucci C; Knorr J; Patel AB; Kinchen K
J Sex Med; 2016 Aug; 13(8):1212-9. PubMed ID: 27329542
[TBL] [Abstract][Full Text] [Related]
13. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects.
Schubert M; Jockenhövel F
J Endocrinol Invest; 2005; 28(3 Suppl):23-7. PubMed ID: 16042356
[TBL] [Abstract][Full Text] [Related]
14. Late-life onset hypogonadism: a review.
Bassil N; Morley JE
Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
[TBL] [Abstract][Full Text] [Related]
15. [Nebido in the treatment of hypogonadism syndrome and its complications in men].
Dedov II; Kurbatov DG; Rozhivanov RV; Lepetukhin AE; Dubskiĭ SA; Goncharov NP
Urologiia; 2011; (6):59-60, 62-7. PubMed ID: 22448484
[TBL] [Abstract][Full Text] [Related]
16. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
Behre HM; Heinemann L; Morales A; Pexman-Fieth C
Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
[TBL] [Abstract][Full Text] [Related]
17. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
[TBL] [Abstract][Full Text] [Related]
18. [Late-onset hypogonadism in men: uncertain disease entity and reservations regarding treatment with testosterone].
Nieuwenhuijzen Kruseman AC
Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1925-8. PubMed ID: 16999276
[TBL] [Abstract][Full Text] [Related]
19. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
[TBL] [Abstract][Full Text] [Related]
20. Testosterone treatment in the aging male: myth or reality?
Nigro N; Christ-Crain M
Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
